(滑动查看全部)
1.Chiu CY, Miller SA. Clinical metagenomics. Nat. Rev. Gen. 2019; 20(6): 341–355. DOI: 10.1038/s41576-019-0113-7.
2.Stefan CP, Koehler JW, Minogue TD. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes. Sci. Rep. 2016; 6: 25904. DOI: 10.1038/srep25904.
3.Loman NJ, Constantinidou C, Christner M, et al. A Culture-Independent Sequence-Based Metagenomics Approach to the Investigation of an Outbreak of Shiga-Toxigenic Escherichia coli O104:H4. JAMA 2013; 309(14): 1502–1510. DOI:10.1001/jama.2013.3231.
4.Lefterova MI, Suarez CJ, Banaei N, Pinsky BA. Next-Generation Sequencing for Infectious Disease Diagnosis and Management: A Report of the Association for Molecular Pathology. J. Mol. Diagn. 2015; 17(6): 623–634. DOI: 10.1016/j.jmoldx.2015.07.004.
5.Xie F, Duan Z, Zeng W, et al. Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia. BMC Infect. Dis. 2021; 21(1): 352. DOI: 10.1186/s12879-021-06039-1.
6.Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat. Microbiol. 2019; 4(4): 663–674. DOI:10.1038/s41564-018-0349-6.
7.7. Jia X, Hu L, Wu M, et al. A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification. Rep. 2021; 11(1): 4405. DOI: 10.1038/s41598-021-83812-x.
8.Jing C, Chen H, Liang Y, et al. Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections. Clin. Chem. 2021; 67(8): 1133–1143. DOI: 10.1093/clinchem/hvab061.
9.Liu D, Zhou H, Xu T, et al. Multicenter assessment of shotgun metagenomics for pathogen detection. EBioMedicine 2021; 74: 103649. DOI: 10.1016/j.ebiom.2021.103649.